{"schema_version":"secwatch.filing_event.v1","accession":"0000947871-23-000333","form_type":"8-K","ticker":"DGX","cik":"0001022079","company_name":"QUEST DIAGNOSTICS INC","filed_at":"2023-03-17T23:59:59+00:00","discovered_at":"2026-05-14T18:03:43.538521+00:00","generated_at":"2026-06-17T23:25:43.179903+00:00","sec_items":["7.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Quest Diagnostics updates 2023-2026 outlook: mid single-digit revenue CAGR, high single-digit adjusted EPS CAGR","bullets":["Reiterates 2023 guidance: revenue $8.83B-$9.03B, base business +2.6%-3.8%, adjusted EPS $8.40-$9.00.","Long-term 2023-2026: mid single-digit revenue CAGR; high single-digit adjusted EPS CAGR.","Invigorate program targets ~3% annual productivity savings via automation, AI, and digital.","Growth initiatives: physician/hospital expansion, molecular genomics, oncology, consumer health.","No change to 2023 guidance; capital deployment strategy discussed without new commitments."],"urls":{"canonical":"https://secwatch.observer/filing/0000947871-23-000333","json":"https://secwatch.observer/filing/0000947871-23-000333.json","markdown":"https://secwatch.observer/filing/0000947871-23-000333.md","text":"https://secwatch.observer/filing/0000947871-23-000333.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1022079/000094787123000333/0000947871-23-000333-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1022079/000094787123000333/ss1867887_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-17T23:25:43.179903+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}